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OBJECTIVE. We describe the spectrum of radiologic appearances of hepatic abscesses in
patients with chronic granulomatous disease (CGD), a hereditary immunodeficiency present-
ing in childhood that occurs at a rate of 1 in 200,000–250,000 live births and predisposes pa-
tients to infection with catalase-positive organisms.
CONCLUSION. Hepatic abscesses in patients with CGD show an atypical radiologic ap-
pearance compared with sporadic hepatic abscesses, and they are characterized by homoge-
neous enhancement and multiseptal enhancement. In the appropriate clinical setting, the ap-
pearance of an enhancing mass should suggest the possibility of a CGD-related hepatic abscess.
epatic abscesses are usually caused
by a bacterial infection associated
with ascending cholangitis or
trauma, among other causes, and
generally they have a well-defined appearance
on CT and MRI. Abscesses typically display a
thin enhancing rim with liquefied nonenhanc-
ing internal contents [1–3]. Histology reveals
active inflammatory cells in the periphery with
necrosis and pus in the center [1, 4]. Hepatic ab-
scesses typically show progressive liquefaction
at their center over the course of 2 weeks [5].
Because of their liquid contents, hepatic ab-
scesses typically respond to a combination of
parenteral antibiotics, percutaneous or open
drainage, or both.
Chronic granulomatous disease (CGD) is
the name used to describe a group of rare im-
mune deficiencies caused by mutations in one
of four genes that encode subunits of phago-
cytic nicotinamide adenine dinucleotide
phosphate (NADPH) oxidase [6–8]. This dis-
ease occurs once in 200,000–250,000 live
births. Although survival into the fourth and
fifth decades is now more common because of
aggressive antibiotic therapy, life expectancy
is typically reduced in most patients. Patients
with CGD are susceptible to catalase-positive
microorganisms such as Staphylococcus au-
reus and fungi that metabolize their own hy-
drogen peroxide [7–9]. Recurrent infections,
especially in the lungs, with certain bacteria
(Staphylococcus aureus, Serratia marce-
scens, Burkholderia cepacia, and Nocardia
species) and fungi (Aspergillus species and
others) are common. In addition, these pa-
tients develop recurrent inflammatory le-
sions, characteristically involving hollow vis-
cera. CGD is diagnosed by showing a
defective oxidative burst in lymphocytes as
shown by nitroblue tetrazolium (NBT) reduc-
tion or dihydror hodamine oxidation.
Instead of forming normal liquefied ab-
scesses, these CGD-associated abscesses
show granulomatous inflammation with a
dense surrounding granulation tissue [8, 10].
Granulomatous abscesses typically contain
an intense leukocytic infiltrate centrally and
granulation or reparative tissue peripherally.
Liver abscesses occur in approximately 50%
of the patients and are typically asymptomatic
or accompanied only by fever. Pain is less fre-
quent, and liver enzyme elevations are incon-
sistent and unhelpful. CGD-associated ab-
scesses thus are difficult to diagnose and do
not typically liquefy, making percutaneous
drainage difficult or impossible [11].
The spectrum of CT and MRI appearances
of hepatic abscess in CGD has not received
much attention in the literature. We report the
CT and MRI appearance of hepatic abscesses in
24 patients with CGD obtained over a 23-year
period. We review the radiologic appearance of
hepatic abscesses in CGD on CT and MRI.
Materials and Methods
We conducted a retrospective review of the im-
aging studies of 47 patients with CGD between
1981 and 2004, selected from a cohort of 194 pa-
tients who were entered in a protocol approved by
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the institutional review board and from whom in-
formed consent was obtained. Selection criteria
included history of liver biopsy, known history of
liver abscess, or progressive thrombocytopenia
that was likely related to splenomegaly. From this
population, 24 patients were found to have clini-
cal imaging and pathologic evidence of one or
more hepatic abscesses. All cases of suspected
hepatic abscess were confirmed with either per-
cutaneous aspiration, surgery, or both, and they
had positive bacteriologic or fungal cultures.
However, if a patient had one positive aspiration,
any remaining hepatic lesions were also assumed
to be an abscess.
Among the 24 patients were 22 males (92%) and
two females (8%). The predominance of males re-
flects the fact that most cases of CGD are X-linked.
At the onset of the abscess, the age range was 3–31
years with a mean of 13.4 years.
A hepatic abscess episode was defined as a pre-
sentation with signs and symptoms of infection ul-
timately diagnosed as a hepatic abscess by histo-
logic or microbiologic criteria. Because CGD
patients are prone to recurrent infections, the num-
ber of episodes of infection and abscesses far ex-
ceeds the number of patients.
In most patients, CT was used as a diagnostic
method and MRI was reserved for patients with al-
lergies or renal insufficiency. Thus, 113 abscesses
were imaged with CT and only 50 were imaged with
MRI. Twelve patients had both MRI and CT during
the same episode. In older patients who did not re-
quire sedation, MRI was used to confirm suspected
findings on CT. Because of the duration of this re-
view (1981–2004), several generations of imaging
equipment were used. CT scans ranged from single-
detector nonhelical to 16-MDCT. Contrast medium
was used (120–140 mL iopamidol [Isovue 300, Bris-
tol-Myers Squibb] after 1986) in all patients except
if contraindicated by a history of allergy.
Similarly, the quality and type of MRI varied
considerably over the duration of this study. MRI
ranged from whole-body coil imaging at 0.5 T
(Vista, Picker International) to torso coil imaging
at 1.5 T (Signa, GE Healthcare). Early studies
were performed at 0.5 T using STIR with the fol-
lowing parameters: TR/TE, 1,500/30; and inver-
sion time (TI), 100 milliseconds. T2-weighted
MRI was performed with 2,000/80, and T1-
weighted MRI was performed with 500/10. Later
in the study, the following sequences were per-
formed on 1.5-T scanners (Signa Horizon, GE
Healthcare): a STIR sequence with a TR/TE range
of 2,000/25–30 and a TI of 150 milliseconds; T2-
weighted fast spin-echo fat-suppressed sequence
with a TR range/TE of 3,000–4,000/102 and echo
train of 4–6; and T1-weighted gradient-echo se-
quence with a TR/TE of 150/4.2 (before and after
IV contrast agent administration using 0.1
mmol/kg gadopentetate dimeglumine after 1988).
In summary, 34 of the 113 CT scans were ob-
tained before the helical CT era, 35 were obtained
during the single-detector helical era, and the re-
maining 44 scans were obtained using a 4- to 16-
MDCT unit. For MRI, 15 examinations were per-
formed on 0.5-T scanners and 35 on 1.5-T scanners.
Note that the protocol for abscesses on MRI (T1-
and T2-weighted or STIR scans followed by a non-
dynamic enhanced fat-suppressed T1-weighted
scan) is not particularly demanding and has been
essentially unchanged for the last 10 years. Thus, a
substantial fraction, 39% for CT and 70% for MRI,
were obtained with modern equipment.The CT and
MRI results were reviewed independently by two
board-certified radiologists who were blinded to
each other’s interpretations, and consensus was
reached regarding the imaging characteristics using
a case report form.
Results
Twenty-four of 47 patients (51%) showed
hepatic abscesses. A total of 151 abscesses
were found in 53 patient episodes, for a
mean of 2.9 abscesses per episode. Follow-
up ranged from 1 to 20 years, with a mean of
10.6 years. It consisted of a combination of
clinical examination and imaging studies.
The length of follow-up was confirmed in
each patient by chart review.
Overall Description
Abscesses of the liver ranged in size from
smaller than 1 cm to 14 cm in diameter (mean,
3.0 cm). The number of episodes per patient
ranged from 1 to 8. The number of abscesses
per patient ranged from 1 to more than 10.
Fourteen patients had only 1 episode, and 10
had more than 1. In 20 episodes, only 1 abscess
appeared; in 33 episodes, more than 1 abscess
was diagnosed. Among recurrent cases of ab-
scess, five patients had a solitary abscess and
19 had multiple abscesses (Fig. 1). Lesions
were found in both the right and left lobes of
the liver, without any specific distribution. His-
tologically, abscesses in the liver in CGD are
irregular and surrounded by layered inflamma-
tion. Frequently, several such abscesses appear
within any given hepatic lesion. The center of
the abscess is filled with neutrophils and cell
debris, and this core is surrounded by palisade
epithelioid histiocytes and then by a layer of
histiocytes mixed with other inflammatory
cells (mainly lymphocytes). Around this is a
wide zone of fibrous and inflamed granulation
tissue. In the periphery of the abscess are nu-
merous small vessels with activated endothe-
lium within a fibrous stroma. The intensity of
inflammation is less than that immediately ad-
jacent to the abscess. Lymphocytes, eosino-
phils, and macrophages are usually present in
this region (Fig. 2).
Imaging Findings
Among the 151 abscesses, 113 underwent
CT and 50 underwent MRI (12 patients had
both studies). The appearance of hepatic ab-
scess varied widely, from homogeneously en-
hancing lesions to highly heterogeneous le-
sions with decreased attenuation on
unenhanced CT scans. The lesions had sharply
defined margins. The patterns of enhance-
ment could be divided into three types
Fig. 1—Scatter chart showing number of abscesses per patient, number of episodes of abscess per patient, and 
number of abscesses per episode. Y-axis represents numerator of each ratio, and size of circle represents 
denominator. Number of abscesses per patient has bimodal distribution with most patients having either 1 or 2 or 
10 or more. Most patients had only a few episodes and only a few abscesses (1 or 2) per episode, but some patients 
showed numerous episodes with multiple abscesses.
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(Fig. 3): type 1, complete central enhance-
ment (i.e., entirely solid) (n = 41); type 2, in-
complete central enhancement subdivided
into type 2a, which showed a small central
area with poor enhancement (n = 71), and
type 2b, which showed peripheral enhance-
ment and a multiseptal core enhancement,
suggesting a multiloculated abscess (n = 22);
and type 3, no central enhancement, the so-
called classic appearance of a hepatic abscess,
with central low attenuation and peripheral
ring enhancement (n = 5) (Fig. 4). Thus, 96%
of the abscesses in this series showed an atyp-
ical appearance on imaging. On CT, 26%
were type 1; 46%, type 2a; 14%, type 2b; and
3%, type 3. On MRI, 22% were type 1; 44%,
type 2a; 24%, type 2b; and 10%, type 3. Thus,
CT and MRI findings showed a very similar
distribution. Note that approximately 60% of
the scans were obtained with helical CT. The
CT appearance of abscesses imaged with
MDCT was qualitatively similar to the that on
the images obtained before the helical CT era.
A relationship was found between lesion
size and the pattern of enhancement
(Fig. 5). If the size of the abscess was 1 cm
or less, most of the abscesses (40/64, or
62.5%) displayed homogeneous and central
enhancement (type 1). If the size of the ab-
scess was 1–3 cm, most of the abscesses
(28/35, or 80%) showed incomplete central
enhancement with small central hypoen-
hancing areas (type 2a). Thirty-seven of 40
(92.5%) of hepatic abscesses larger than 3
cm appeared heterogeneous in enhancement
and multiloculated with peripheral enhance-
ment (types 2a and 2b). Type 3, the most
common appearance of abscesses in the
general population, was distinctly unusual
in this series of CGD patients. These lesions
tended to be larger with measurements of
2.5, 2.8, 4 , 4, and 5 cm for a mean of 3.7 cm
(range, 2.5–5 cm).
MRI
On T1-weighted MR images, abscesses
showed homogeneous low signal intensity
relative to the surrounding liver. On STIR
and fat-suppressed T2-weighted images, the
abscesses showed heterogeneously high sig-
nal intensity. The enhancement patterns on
MRI were similar to the patterns described
for CT (Fig. 6).
Because of the retrospective nature of this
study, not all patients had both CT and MRI.
Therefore, a comparison of sensitivities was
not possible.
Additional Findings
Calcifications
Approximately 33% (8/24) of patients who
had had abscesses in the past showed punctate
calcifications within the hepatic parenchyma at
the site of the prior abscess (Fig. 7). When fol-
lowed over time, the number of hepatic calcifi-
cations increased related to repeated infections
with subsequent granuloma formation.
Postoperative Findings
Surgical drainage was usually required for
treatment because the semisolid nature of the
lesions made them unsuitable for percutane-
ous drainage. Several attempts were made to
drain these abscesses percutaneously early in
our experience but these proved unsuccessful,
and since then surgery has become the stan-
dard method of treatment [12]. As a result,
these patients showed extensive postoperative
changes (lobulated contour and scarring) dur-
ing the follow-up period.
Unusual Features
The individual severity of hepatic ab-
scesses varied significantly among patients.
One patient presented with five large hepatic
abscesses requiring surgical drainage and two
intrasplenic abscesses in a subcapsular re-
gion. He died related to an inferior vena cava
thrombosis 3 months after surgery for the
hepatosplenic abscesses. Another patient de-
veloped more than 20 small abscesses in the
liver, each measuring less than 1 cm, during a
single episode.
A B
Fig. 2—16-year-old boy with chronic granulomatous disease (CGD) shows typical histologic appearance of hepatic abscess.
A, Unlike most abscesses, center of abscess in CGD is filled with neutrophils and cell debris, and this core is surrounded by palisade epithelioid histiocytes and then by layer 
of histiocytes mixed with other inflammatory cells (mainly lymphocytes). Around this is wide zone of fibrous and inflamed granulation tissue. Typical abscesses showed 
liquified necrosis centrally. (H and E, ×40)
B, Higher magnification of vascular granulation tissue surrounding abscess shows numerous small vessels with activated endothelium within fibrous stroma. Lymphocytes, 
eosinophils, and macrophages are present in this region as well. (H and E, ×200)
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One patient with a hepatic abscess also pre-
sented with a left paraaortic hypodense mass
with multiple enlarged retroperitoneal lymph
nodes in the gastrohepatic ligament consis-
tent with a clinical diagnosis of retroperito-
neal adenitis. Among the 24 patients with he-
patic abscess, 8 also developed splenic
abscesses, and 2 cases of retroperitoneal ad-
enitis were encountered.
Discussion
Pyogenic hepatic abscesses are usually
caused by gram-negative bacilli [3, 4]. An in-
oculum of bacteria leads to an initial inflam-
matory response; as macrophages destroy
healthy and infected tissue, the center of the
nascent abscess necroses and its contents liq-
uefy. The abscess becomes walled off from
healthy tissue and a low-grade inflammatory
response develops. Sporadic hepatic abscesses
typically occur as single events because of
trauma or sepsis, and recurrences are unusual.
Because of their liquefied centers, they are of-
ten amenable to percutaneous drainage.
CGD, however, is a rare condition in
which neutrophils and macrophages are un-
able to generate superoxide [6, 8]. As a re-
sult, the lungs and liver develop recurrent ab-
A B
C D
Fig. 3—Patterns of enhancement on CT and MRI of hepatic abscess in patients with chronic granulomatous disease.
A, Drawing shows type 1, complete central enhancement.
B and C, Drawings show type 2, incomplete central enhancement. Type 2 is subdivided into type 2a (B), small central area with poor enhancement, and type 2b (C), peripheral 
enhancement and multiseptal core enhancement suggesting multiloculated abscess.
D, Drawing shows type 3, peripheral ring enhancement surrounding necrotic liquefied cavity.
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scesses and infections. As we have shown,
CGD abscesses are often multiple during
each episode, and patients with CGD often
have multiple episodes of hepatic infection
leading to progressive calcification and scar-
ring. Unlike the sporadic abscess, the liver
abscess in CGD is typically caused by Sta-
phylococcus aureus and some fungi. These
infections result in the formation of granulo-
mas, some of which scar and calcify. Others
lead to clinical symptoms of abscess and de-
velop a granulomatous reaction that is sur-
rounded by granulation tissue.
The hepatic abscesses associated with
CGD have several imaging characteristics
that differentiate them from most sporadic
hepatic abscesses. Whereas sporadic ab-
scesses usually show central cystic cavities
[4, 13], the abscesses associated with CGD
tend to remain homogeneously enhancing
while small and then develop multiple loc-
ules separated by thick enhancing septations
as they enlarge [12]. There is often an in-
tense halo of enhancement around the ab-
scess, likely representing granulation tissue.
The locules may be quite small, and the pre-
dominant appearance may be one of a solid
vascular lesion.
As a consequence of this reactive tissue ar-
chitecture, it is difficult to drain CGD hepatic
abscesses percutaneously, and surgical inter-
vention with manual débridement may be re-
quired [11]. Because patients with CGD often
have poor healing confounded by granuloma
formation, repeated surgeries may lead to se-
vere scar formation and deformation of the
hepatic contour.
CGD patients who develop fever without a
clear source should undergo CT of the chest
A B
C D
Fig. 4—Hepatic abscess in patients with chronic granulomatous disease showing different patterns of enhancement.
A, 15-year-old boy with homogeneous enhancement (type 1).
B, Same patient and episode as A (type 2a): predominance of homogeneous enhancement with small central area with poor enhancement.
C, 25-year-old man with peripheral and multiseptal enhancement (type 2b).
D, 3-year-old boy with central low attenuation and peripheral ring enhancement (type 3).
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Fig. 5—This graph depicts relative frequency of each 
type of abscess based on lesion size. Most small 
abscesses (≤ 1 cm) display homogeneous 
enhancement (type 1), whereas 80% of abscesses 
between more than 1 cm and 3 cm show incomplete 
central enhancement with small central 
hypoenhancing area (type 2a). Most abscesses larger 
than 3 cm show either type 2a (incomplete central 
enhancement) or type 2b (multiloculated with 
peripheral enhancement).
A B
C D
Fig. 6—Patterns of enhancement of hepatic abscess in patients with chronic granulomatous disease (CGD) on MRI are similar to CT.
A and B, 3-year-old boy with homogeneous enhancement hepatic abscess (type 1) on T1-weighted contrast-enhanced (A) and mild increased signal intensity on STIR (B) images.
C and D, 15-year-old boy presents with enhancing hepatic lesion and low-signal central area (type 2a) on T1-weighted contrast-enhanced (C) and moderately increased signal 
intensity on STIR (D) images.
(Fig. 6 continues on next page)
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and abdomen. The latter should be performed
after IV contrast medium to help identify typi-
cal lesions. A single venous phase scan is usu-
ally sufficient in such patients because the sep-
tal thickening requires approximately 1 minute
to enhance. MRI of the abdomen should in-
clude a T1-weighted, T2-weighted, and gado-
linium-enhanced T1-weighted axial scan and
should be performed if CT is negative or equiv-
ocal. MRI should also be used in patients with
a history of iodinated contrast allergy or renal
insufficiency. MRI does not expose affected
children to radiation. CGD patients often un-
dergo multiple radiographic examinations, and
cumulative ionizing radiation may be a cause
for concern. Therefore, MRI is a radiation-free
alternative to CT for diagnosing and following
hepatic abscesses. Sonography, which in the-
ory is an ideal alternative, is limited because
the lesions are often isoechoic with the liver
parenchyma. In addition, because the liver is
usually scarred, the sonographic appearance is
complex. The abscesses are not cystic, so they
can be difficult to distinguish from scars and
calcifications, which are common. Moreover,
in many children, prior scarring and surgical
defects make differentiation of active and inac-
tive abscesses problematic without the use of
contrast medium. We have no experience with
sonographic contrast agents in this setting, but
they are a reasonable consideration. In reality,
when patients present with fever and a history
of CGD, the first test obtained is CT of the
chest and abdomen to exclude both pulmonary
and abdominal infection. If the result of the CT
is clearly negative, no further testing is needed.
If, however, some doubt exists, the findings
can be confirmed with hepatic MRI.
We propose a classification system for he-
patic abscesses in CGD based on what ap-
pears to be the evolution of such lesions. The
major purpose of this classification is to edu-
cate imagers regarding the different patterns
of CGD-associated abscesses. In this classifi-
cation, type 1 lesions are homogeneously en-
hancing, type 2 lesions show incomplete or
septated central radiolucency with a thick en-
hancing wall, and type 3 lesions contain a liq-
E F
G H
Fig. 6 (continued)—Patterns of enhancement of hepatic abscess in patients with chronic granulomatous disease (CGD) on MRI are similar to CT.
E and F, 11-year-old boy shows hepatic abscess with peripheral and septal enhancement (type 2b) on T1-weighted contrast-enhanced image (E). On STIR image (F), this lesion 
shows moderate but homogeneous intensity.
G and H, 15-year-old boy presents so-called classic appearance of abscess with enhancing ring and necrotic central area (type 3) on T1-weighted contrast-enhanced image 
(G). On STIR image (H), signal intensity is slightly higher centrally within cavity compared with periphery.
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uefied center with a thin enhancing wall.
Small lesions (1 cm or less) are usually homo-
geneously enhancing (type 1). Intermediate
lesions (> 1–3 cm in diameter) often have
nonenhancing small central areas (type 2a).
Larger lesions (> 3 cm) show either type 2a
(incomplete central enhancement) or type 2b
(multiloculated with peripheral enhance-
ment) characteristics. The most unusual ap-
pearance for a CGD hepatic abscess is the
most common appearance for a sporadic he-
patic abscess: a cavitary lesion with an en-
hancing rim (type 3) seen in only approxi-
mately 3% of the abscesses in this series.
This study has a number of limitations.
Because the imaging was performed over 20
years, imaging technology was not consis-
tent. Partial volume averaging effects on
older scanners with 1-cm collimation could
have resulted in a higher percentage of le-
sions considered to be type 1 versus type 2.
However, the fundamental types of ab-
scesses described here will not vary signifi-
cantly. A substantial proportion of the pa-
tients in this series (39–70%) were scanned
with modern equipment. In addition, we did
not routinely obtain multiphasic CT or MRI
after contrast administration. This is because
the patients are usually children, and at-
tempts are made to minimize radiation expo-
sure or time in the scanner. It might be inter-
esting to examine dynamic enhanced MRI of
such lesions, however.
A B
C D
Fig. 7—Long-term sequelae of hepatic abscesses in chronic granulomatous disease (CGD). Calcifications scattered within hepatic parenchyma of different patients with 
CGD.
A, 37-year-old man with punctate calcifications near dome of liver because of previous abscess associated with scarring.
B, 39-year-old man with scattered punctate calcifications without scarring.
C, 12-year-old boy also with scattered punctate calcifications, indicating this process can occur early in life.
D, 39-year-old man showing masslike calcifications within liver at site of previous abscess.
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In conclusion, hepatic abscesses in patients
with CGD have characteristic imaging appear-
ances that include homogeneously enhancing
lesions, a vascular abscess wall, and multilocu-
lated chambers. Small solid enhancing hepatic
lesions in a young patient with CGD are highly
indicative of acute hepatic abscesses that re-
quire early treatment. These lesions should not
be mistaken for other noninfectious vascular
hepatic lesions such as adenomas or metastatic
disease. Moreover, because they are nonlique-
fied, they are difficult to drain percutaneously.
The diagnosis can be made on CT or MRI, but
the latter shows smaller lesions more readily
and spares radiation exposure in young chil-
dren. Repeated abscess formation leads to he-
patic scarring and calcifications, which may
compromise hepatic function. Although there
is overlap with sporadic hepatic abscess, in the
appropriate setting the findings described here
are highly suggestive of CGD-related hepatic
abscess.
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